Doctor shopping is the practice of visiting multiple healthcare providers to obtain prescriptions for controlled substances without letting each provider know about the others. The term most often comes up in the context of opioids, sedatives, and stimulants, but it covers any situation where a patient uses fraud, deception, or concealment to accumulate medications from different sources. While the phrase carries a strong association with drug misuse, the reality is more nuanced: not all doctor shopping is driven by addiction, and understanding the full picture matters.
How Doctor Shopping Works
At its core, doctor shopping relies on information gaps between providers. A patient sees one doctor and receives a prescription for a controlled substance, then visits a second (or third, or fourth) doctor for the same complaint, deliberately withholding the fact that they already have an active prescription. Each provider, unaware of the other visits, writes a new prescription, and the patient fills them at different pharmacies.
The medications most commonly obtained this way are opioid painkillers, which account for roughly 12.8% of doctor shopping cases in studies that have tracked it. Sedatives like benzodiazepines come next at about 4.2%, followed by stimulants at 1.4% and weight-loss medications at about 0.9%. The pattern is concentrated among a small group: research from France’s national monitoring system found that 8.5% of patients engaged in doctor shopping accounted for 45.4% of the total quantity of medications obtained through this behavior.
Why People Doctor Shop
The most studied motivation is substance misuse. Doctor shopping has long been described as a traditional method for acquiring drugs illicitly, and patients in drug and alcohol treatment programs have reported that shopping for benzodiazepines, in particular, was easily accomplished. For people struggling with addiction or dependence, visiting multiple prescribers can feel like the path of least resistance compared to buying drugs on the street.
But addiction is only part of the story. Patients also visit multiple doctors because their symptoms persist and they feel their current provider hasn’t helped. Some don’t understand or accept the diagnosis they were given. Others are dealing with chronic conditions and cycle through providers out of frustration when treatment isn’t working. Research has identified several doctor-side factors too: inconvenient office hours, long waiting times, poor communication, and a provider’s personal manner all push patients to seek care elsewhere. In one U.S. community study, these practical and interpersonal barriers were significant predictors of patients switching doctors repeatedly.
There’s also a psychological dimension. Patients with medically unexplained symptoms, or those who tend to experience emotional distress as physical complaints (a pattern sometimes called somatization), visit more providers at higher rates. For these patients, the drive isn’t to stockpile medication. It’s to find someone who will take their symptoms seriously. The distinction matters because the appropriate response, whether from healthcare systems or policymakers, looks very different depending on the underlying cause.
Health Risks of Fragmented Care
Whatever the motivation, seeing multiple providers without coordinating care creates real medical danger. The most immediate risk is polypharmacy: taking multiple medications, sometimes overlapping or interacting, without any single provider having the full picture. Opioids combined with benzodiazepines, for example, significantly increase the risk of fatal respiratory depression. Studies have found that doctor and pharmacy shopping involving controlled substances is directly associated with drug-related death.
Beyond overdose risk, fragmented care means no one provider can manage a condition effectively. Each new doctor starts from scratch, potentially ordering duplicate tests, missing important history, or prescribing treatments that conflict with what another provider already started. Continuity of care, the ongoing relationship between a patient and a provider who knows their full history, is one of the strongest predictors of good health outcomes. Doctor shopping disrupts that continuity by design. The result is often worse disease management, higher costs for both the patient and the healthcare system, and longer waits as each new provider works through the same diagnostic process from the beginning.
How States Define It Legally
Doctor shopping is illegal in every U.S. state, though the specific language varies. Most states use what the CDC classifies as “general” doctor shopping laws, which prohibit obtaining controlled substances through fraud, deceit, misrepresentation, subterfuge, or concealment of a material fact. This language traces back to the Uniform Narcotic Drug Act, one of the earliest model laws addressing drug acquisition.
Twenty states go further with “specific” doctor shopping laws that explicitly target the act of withholding prescription information from a current provider. South Dakota’s law, for instance, makes it a crime for any person who knowingly obtains a controlled substance from a medical practitioner while knowingly withholding the fact that they have already obtained a controlled substance elsewhere. Delaware, California, and Rhode Island use similar frameworks, with some states maintaining multiple overlapping statutes. The key legal element across all of them is intent: the patient must knowingly conceal or deceive. Simply visiting multiple doctors for legitimate reasons, like seeking a second opinion, is not doctor shopping in the legal sense.
Penalties vary by state and typically depend on the substance involved and the number of offenses. Doctor shopping charges can range from misdemeanors to felonies, with consequences including fines, probation, and prison time. Because the behavior involves controlled substances, convictions can also trigger additional consequences like loss of professional licenses or eligibility restrictions for certain programs.
How Prescription Monitoring Catches It
The primary tool for detecting doctor shopping is the prescription drug monitoring program, or PDMP. Every state now operates an electronic database that tracks controlled substance prescriptions, recording which patient received what drug, from which prescriber, and at which pharmacy. When you fill a prescription for a controlled substance, that information is logged in the system.
Providers and pharmacists can check the PDMP before writing or dispensing a prescription, and many states now require them to do so. If a patient has filled similar prescriptions from multiple providers in a short window, the PDMP flags it. Some systems go a step further by sending proactive alerts to providers when a patient’s pattern suggests high-risk behavior, without waiting for the provider to run a search. Evaluations of these programs have shown measurable changes: prescribing patterns shift, patients are less likely to visit multiple providers for the same controlled substance, and admissions to substance use treatment programs have decreased in some areas.
PDMPs have made the kind of doctor shopping that was common in the 1990s and 2000s significantly harder to pull off undetected. However, they are not foolproof. Interstate data sharing is still inconsistent, and patients who cross state lines can sometimes exploit gaps between systems. The databases also raise privacy concerns, and their effectiveness depends on how consistently providers actually check them before prescribing.
The Line Between Shopping and Seeking Help
One of the complications with the term “doctor shopping” is that it lumps together very different behaviors under one label. A person forging symptoms to stockpile opioids and a person with chronic pain who feels dismissed by their current provider and seeks another opinion are doing superficially similar things, but for fundamentally different reasons. Research consistently emphasizes that not all doctor shopping is driven by suspect motivations.
This distinction has practical implications. Systems designed purely to restrict access, like mandatory PDMP checks or limits on prescriptions, can catch people engaged in genuine drug diversion. But they can also create barriers for patients with legitimate, undertreated pain or complex conditions that don’t respond to first-line treatment. A patient who has bounced between three providers because none could explain their symptoms isn’t necessarily doing anything wrong. They may be experiencing the healthcare system’s own gaps in communication, access, and chronic disease management. Addressing doctor shopping effectively means distinguishing between diversion and desperation, and responding to each one appropriately.